Qureshi, Mohammad
Qureshi, Mohammad was paid $818K by Medicaid between Jan 2018 and Jan 2023, across 11 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 82% of everything it billed.
33Billing provider infoQURESHI, MOHAMMAD
EDISON, NJ 08837
EDISON, NJ 08837
33aNPI1174525604assigned 08/15/2005
33bProvider typeSpecialist
28Total paid$818K
24GClaims18,827
24DCodes billed11
24AFirst – last monthJan 2018 – Jan 2023
Compared with peers
Next to other Specialist providers in New Jersey
Rank by total paid#63 of 378
Median peer was paid$63K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 111 | $754.48 | |
| 2019 | 13 | $172.20 | |
| 2020 | 3,442 | $238K | |
| 2021 | 12,813 | $497K | |
| 2022 | 2,398 | $81K | |
| 2023 | 50 | $2K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 82% | 10,490 | 8,430 | $669K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 16% | 7,025 | 5,345 | $129K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.2% | 872 | 736 | $10K |
| 87631 | <1% | 47 | 47 | $3K | |
| 87486 | <1% | 162 | 156 | $3K | |
| 87507 | <1% | 49 | 45 | $3K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 100 | 100 | $821.56 |
| 87581 | <1% | 16 | 16 | $343.20 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 16 | 16 | $343.20 |
| 88312 | <1% | 24 | 24 | $105.12 | |
| 83993 | <1% | 26 | 25 | $67.68 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.